Document is current

Any future updates will be listed below

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s00535-024-02159-y

Published Online: 2024-10-21

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark